Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia

Peer Review reports

Original Submission
3 Nov 2021	Submitted	Original manuscript
3 Jan 2022	Reviewed	Reviewer Report
13 Jan 2022	Reviewed	Reviewer Report - Masakazu Hatano
17 Feb 2022	Author responded	Author comments - Jacqueline A. Pesa
23 Feb 2022	Reviewed	Reviewer Report
24 Feb 2022	Reviewed	Reviewer Report - Masakazu Hatano
7 Mar 2022	Author responded	Author comments - Jacqueline A. Pesa
Resubmission - Version 2
17 Feb 2022	Submitted	Manuscript version 2
Publishing
14 Mar 2022	Editorially accepted
9 Apr 2022	Article published	10.1186/s12888-022-03895-2

Back to article page